Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. [electronic resource]
Producer: 20100622Description: 833-841 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor -- metabolism
- Cyclin-Dependent Kinase Inhibitor p27 -- metabolism
- Cyclophosphamide
- Doxorubicin
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Male
- Middle Aged
- Prednisone
- Prognosis
- Retrospective Studies
- Rituximab
- S-Phase Kinase-Associated Proteins -- metabolism
- Survival Analysis
- Vincristine
- Young Adult
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.